Melanie Davies

Melanie Jane Davies
CBE, FMedSci
Born (1961-07-08) 8 July 1961 (age 64)

Melanie Jane Davies, CBE, MBChB, MD, FRCP, FRCGP, FMedSci (born 8 July 1961) is a British physician and academic specialising in type 2 diabetes. She is Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at University Hospitals of Leicester NHS Trust. Davies is Co-Director of the Leicester Diabetes Centre, a collaboration between the University of Leicester and University Hospitals of Leicester NHS Trust, based at Leicester General Hospital[1][2].

Career

Davies’ research focuses on the causes, prevention, and self-management of type 2 diabetes, including early onset type 2 diabetes. She has contributed to clinical trials and international consensus guidelines on diabetes care[3].

Roles

  • Director, NIHR Leicester Biomedical Research Centre[4]
  • NIHR Senior Investigator Emeritus
  • Co-chair, EASD/ADA Consensus Report on Type 2 Diabetes Management[5]
  • National Specialty Lead, Research Delivery Network for Diabetes, Metabolic and Endocrine[6]

Research and Publications

Davies has authored numerous peer-reviewed articles on diabetes and related conditions. Her work has appeared in journals such as The Lancet, New England Journal of Medicine, and Diabetes Care[7].

Selected Publications

NEJM 2025 – CagriSema Trial

Lancet 2024 – Semaglutide HFpEF

NEJM 2021 – Semaglutide Obesity

Diabetes Care 2018 – Consensus Report

Lancet 2017 – Type 2 Diabetes

Diabetologia 2012 – Sedentary Time

BMJ 2008 - Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial

Clinical Science 1993 – Antioxidant Capacity

Awards and Honours

  • Commander of the Order of the British Empire (CBE) for services to diabetes research (2016)[8]
  • Fellow of the Academy of Medical Sciences (2018)[9]
  • Outstanding Achievement in Clinical Diabetes Research Award, American Diabetes Association (2025)[10]

References

  1. ^ "Melanie Davies | Explore Diabetes Innovations". Leicester Diabetes Centre. 13 October 2025. Retrieved 8 December 2025.
  2. ^ "Melanie Davies". University of Leicester. Retrieved 8 December 2025.
  3. ^ "About Melanie Davies". easd-elearning.eu. Retrieved 8 December 2025.
  4. ^ Jones, Joanna (24 June 2025). "BRC Director celebrated with US award". NIHR Leicester Biomedical Research Centre. Retrieved 8 December 2025.
  5. ^ "About Melanie Davies". easd-elearning.eu. Retrieved 8 December 2025.
  6. ^ "Melanie Davies | Explore Diabetes Innovations". Leicester Diabetes Centre. 13 October 2025. Retrieved 8 December 2025.
  7. ^ Davies, Melanie J.; Aroda, Vanita R.; Collins, Billy S.; Gabbay, Robert A.; Green, Jennifer; Maruthur, Nisa M.; Rosas, Sylvia E.; Del Prato, Stefano; Mathieu, Chantal; Mingrone, Geltrude; Rossing, Peter; Tankova, Tsvetalina; Tsapas, Apostolos; Buse, John B. (28 September 2022). "Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)". Diabetes Care. 45 (11): 2753–2786. doi:10.2337/dci22-0034. ISSN 0149-5992. Archived from the original on 5 August 2025.
  8. ^ "Melanie Davies". University of Leicester. Retrieved 8 December 2025.
  9. ^ "Professor Melanie Davies". acmedsci.ac.uk. Retrieved 8 December 2025.
  10. ^ "2025 Outstanding Achievement in Clinical Diabetes Research Award | American Diabetes Association". professional.diabetes.org. Retrieved 8 December 2025.
allikas: http://en.wikipedia.org/wiki/Melanie_Davies